Pune: A govt resolution issued on Jan 16 said the state would now charge for every single service, which were free or cost minimal over the last two y.
Please provide your email address to receive an email when new articles are posted on . IV iron is the most cost-effective option for women with iron deficiency anemia and heavy menstrual bleeding.
A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new research published in ...
The block is hot in Chicago. In "Power Book IV: Force," Tommy Egan (Joseph Sikora) will do anything to remain in control and keep his secrets from coming to the surface. Even if that means shots need ...
Intravenous (IV) and subcutaneous (SC) formulations each play important roles in modern oncology care, with distinct strengths and limitations. IV administration offers established dosing precision, ...
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium Subcutaneous amivantamab-lazertinib demonstrated noninferior ...
“Power Book IV: Force” is here with its third and final season on Starz. The hit spinoff from the original Starz series “Power,” follows James “Ghost” St. Patrick’s best friend in crime Tommy Egan as ...
The FDA approved an intravenous (IV) formulation of fosfomycin (Contepo) to treat adults with complicated urinary tract infection (cUTI), including acute pyelonephritis, caused by susceptible ...
We report the case of a postmenopausal woman with a synchronous obstructing intrinsic endometrioma of the left ureter and a coexistent periurethral leiomyoma. Endometriosis in postmenopausal women is ...
Hurricane Helene left a trail of devastation and destruction last year, dumping 40 trillion gallons of water on the Southeast. It leveled houses, sent trees crashing and left millions without power.
Please provide your email address to receive an email when new articles are posted on . The 13 patients who completed the trial were given five intravenous treatments of ANXV (Annexin Pharmaceuticals) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results